Table 3 Cross tab data analysis; determining the significance of categorised variables on likelihood to present at follow-up or in interval
Descriptive statistic: | Detected at follow-up: | Detected in interval: | p. value: |
|---|---|---|---|
Gender; | .413 | ||
Female | 8 (21.6%) | 29 (78.4%) | |
Male | 15 (26.3%)′ | 42 (73.7%) | |
Deprivation score; | .341 | ||
1(most deprived) | 3 (60.0%) | 2 (40.0%) | |
2 | 3 (33.3%) | 6 (66.7%) | |
3 | 6 (27.3%) | 16 (72.7%) | |
4 | 7 (25.9%) | 20 (74.15) | |
5(least deprived) | 4 (12.9%) | 27 (87.1%) | |
Rurality; | .571 | ||
Urban | 14 (32.6%) | 29 (67.4%) | |
Rural | 9 (17.6%) | 42 (82.4%) | |
Melanoma type; | .964 | ||
Superficial spreading | 7 (25.9%) | 20 (74.1%) | |
Nodular malignant | 8 (26.7%) | 22 (73.3%) | |
Lentigo maligna | 1 (20.0%) | 4 (80.0%) | |
Acral lentiginous | 1 (20.0% | 4 (80.0%) | |
Other | 6 (22.2%) | 21 (77.8%) | |
Breslow thickness; | .252 | ||
4 mm or less | 11 (20.0%) | 44 (80.0%) | |
>4 mm | 12 (30.8%) | 27 (69.2%) | |
Age at Dx; | .142 | ||
Up to 65 years | 12 (25.0%) | 36 (75%) | |
65 years and above | 18 (39.1%) | 28 (60.9%) | |
Time to recurrence; | .008 | ||
12 months or less | 14 (51.9%) | 13 (48.1%) | |
Beyond 12 months | 16 (23.9%) | 51 (76.2%) |